Phase I results of human endogenous retrovirus type-E (HERV-E) TCR transduced T-cells in patients (pts) with metastatic clear cell renal cell carcinoma (mccRCC)
Nadal, Rosa, Barisic, Stefan, Scurti, Gina M., Cherkasova, Elena, Chen, Long, Wood, Kristen, Highfill, Steven L., Wells, Brian, Aue, Georg, Shalabi, Reem, Hughes, Thomas E., Tian, Xin, Xu, Yifei, Malayeri, Ashkan A., Bagheri, Mohammadhadi H., Reger, Robert N., Nishimura, Michael I., Childs, Richard W.
Published in Journal of clinical oncology (01.06.2023)
Published in Journal of clinical oncology (01.06.2023)
Get full text
Journal Article
Preliminary results of a phase I clinical trial using an autologous dendritic cell cancer vaccine targeting HER2 in patients with metastatic cancer or operated high-risk bladder cancer (NCT01730118)
Maeng, Hoyoung M., Wood, Lauren Virginia, Moore, Brittni, Bagheri, Mohammadhadi H., Webb, Santhana, England, Lee, Martinez, Giselle, Steinberg, Seth M., Pack, Svetlana, Stroncek, David, Morris, John Charles, Terabe, Masaki, Berzofsky, Jay A.
Published in Journal of clinical oncology (20.05.2019)
Published in Journal of clinical oncology (20.05.2019)
Get full text
Journal Article
Phase I expansion study of cabozantinib plus nivolumab (CaboNivo) in metastatic urothelial carcinoma (mUC) patients (pts) with progressive disease following immune checkpoint inhibitor (ICI) therapy
Girardi, Daniel da Motta, Niglio, Scot Anthony, Mortazavi, Amir, Lara, Primo, Pal, Sumanta K., Saraiya, Biren, Cordes, Lisa M., Ley, Lisa, Sierra Ortiz, Olena, Cadena, Jacqueline, Diaz, Carlos, Bagheri, Mohammadhadi H., Steinberg, Seth M., Costello, Rene, Streicher, Howard, Wright, John, Parnes, Howard L., Ning, Yang-Min, Bottaro, Donald P., Apolo, Andrea B.
Published in Journal of clinical oncology (20.05.2020)
Published in Journal of clinical oncology (20.05.2020)
Get full text
Journal Article
Ipilimumab challenge/re-challenge in metastatic urothelial carcinoma (mUC) and other genitourinary (GU) tumors treated with cabozantinib+nivolumab (CaboNivo) or cabozantinib+nivolumab+ipilimumab (CaboNivoIpi)
Niglio, Scot Anthony, Girardi, Daniel da Motta, Mortazavi, Amir, Lara, Primo, Pal, Sumanta K., Saraiya, Biren, Cordes, Lisa M., Ley, Lisa, Sierra Ortiz, Olena, Cadena, Jacqueline, Diaz, Carlos, Bagheri, Mohammadhadi H., Steinberg, Seth M., Costello, Rene, Streicher, Howard, Wright, John, Parnes, Howard L., Ning, Yang-Min, Bottaro, Donald P., Apolo, Andrea B.
Published in Journal of clinical oncology (20.05.2020)
Published in Journal of clinical oncology (20.05.2020)
Get full text
Journal Article
Clinical efficacy of cabozantinib plus nivolumab (CaboNivo) and CaboNivo plus ipilimumab (CaboNivoIpi) in patients (pts) with chemotherapy-refractory metastatic urothelial carcinoma (mUC) either naïve (n) or refractory (r) to checkpoint inhibitor (CPI)
Nadal, Rosa, Mortazavi, Amir, Stein, Mark N., Pal, Sumanta K., Lee, Daniel K, Parnes, Howard L., Ning, Yang-Min, Cordes, Lisa M., Bagheri, Mohammadhadi H., Thompson, Ryan, Mayfield, Christian, Steinberg, Seth M., Monk, Paul, Lara, Primo, Costello, Rene, Agarwal, Piyush K., Bottaro, Donald, Dahut, William L., Apolo, Andrea B.
Published in Journal of clinical oncology (20.05.2018)
Published in Journal of clinical oncology (20.05.2018)
Get full text
Journal Article
Results of phase I plus expansion cohorts of cabozantinib (Cabo) plus nivolumab (Nivo) and CaboNivo plus ipilimumab (Ipi) in patients (pts) with with metastatic urothelial carcinoma (mUC) and other genitourinary (GU) malignancies
Nadal, Rosa Maria, Mortazavi, Amir, Stein, Mark, Pal, Sumanta K., Davarpanah, Nicole N., Parnes, Howard L., Ning, Yang-Min, Cordes, Lisa M., Bagheri, Mohammadhadi H., Lindenberg, Liza, Thompson, Ryan, Steinberg, Seth M., Moore, Tina, Lancaster, Tiffany, Velez, Milisyaris, Mena, Esther, Costello, Rene, Bottaro, Donald, Dahut, William L., Apolo, Andrea B.
Published in Journal of clinical oncology (20.02.2018)
Published in Journal of clinical oncology (20.02.2018)
Get full text
Journal Article
A phase I study of cabozantinib plus nivolumab (CaboNivo) and cabonivo plus ipilimumab (CaboNivoIpi) in patients (pts) with refractory metastatic (m) urothelial carcinoma (UC) and other genitourinary (GU) tumors
Apolo, Andrea B., Mortazavi, Amir, Stein, Mark N., Davarpanah, Nicole N., Nadal, Rosa Maria, Parnes, Howard L., Ning, Yangmin M., Francis, Deneise C, Cordes, Lisa M, Berniger, Marilise Anne, Steinberg, Seth M., Agarwal, Piyush K., Bagheri, Mohammadhadi H., Nanda, Swati, Monk, Paul, Lancaster, Tiffany, Moore, Tina, Costello, Rene, Bottaro, Donald P., Pal, Sumanta K.
Published in Journal of clinical oncology (20.05.2017)
Published in Journal of clinical oncology (20.05.2017)
Get full text
Journal Article